Experiment: 9RXE

Solution structure of the HR1c domain of human PKN1

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	1.6 mM [U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
2	2D 1H-13C HSQC	1.2 mM [U-100% 13C; U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
3	3D CBCA(CO)NH	1.2 mM [U-100% 13C; U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
4	3D HNCA	1.2 mM [U-100% 13C; U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
5	3D HNCACB	1.2 mM [U-100% 13C; U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
6	3D HN(CO)CA	1.2 mM [U-100% 13C; U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
7	3D 1H-15N NOESY	1.6 mM [U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
8	3D HCCH-TOCSY	1.2 mM [U-100% 13C; U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
9	3D 1H-15N TOCSY	1.6 mM [U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker DRX 500
10	3D 1H-13C NOESY	1.2 mM [U-100% 13C; U-100% 15N] PRK1 HR1c domain, 150 mM sodium chloride, 20 mM sodium phosphate, 90 % H2O, 10 % [U-2H] D2O, 0.05 % w/v sodium azide	90% H2O/10% D2O	0.17 M	7.3	1 atm	298	Bruker AVANCE 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	DRX	500
2	Bruker	AVANCE	800

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	45
Representative Model	1 (closest to the average)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	CcpNmr Analysis	2.4	CCPN
2	structure calculation	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
3	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
4	peak picking	CcpNmr Analysis	2.4	CCPN

RCSB PDB is hosted by

RCSB PDB is a member of

RCSB Partners
Nucleic Acid Knowledgebase

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

9RXE | pdb_00009rxe

Solution structure of the HR1c domain of human PKN1